Kazia Therapeutics Appoints James Levine as Chief Financial Officer

Go back to Kazia Therapeutics Appoints James Levine as Chief Financial Officer
(NASDAQ: KZIA) Delayed: 12.81 -0.01 (0.08%)
Previous Close $12.82    52 Week High
Open $13.13    52 Week Low
Day High $13.55    P/E N/A 
Day Low $12.52    EPS
Volume 96,548